A new commentary from HESI Global’s Emerging Systems Toxicology for the Assessment of Risk (eSTAR) Committee, “Navigating complexity in modern toxicology: the role of omics in short-term in vivo studies,” offers a forward-looking perspective on how omics technologies are transforming chemical risk assessment.
Read the full article here:
Mitchell et al., 2025. Navigating complexity in modern toxicology: the role of omics in short-term in vivo studies. Toxicological Sciences. https://doi.org/10.1093/toxsci/kfaf120
hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.